MetLife Cash & Equivalents increased by 3.0% to $22.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $21.33B to $22.69B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 2.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.04B | $18.96B | $20.05B | $23.49B | $20.55B | $22.20B | $20.20B | $18.46B | $15.42B | $14.91B | $20.64B | $19.84B | $20.79B | $21.77B | $20.07B | $21.33B | $22.18B | $20.23B | $22.03B | $22.69B |
| QoQ Change | — | -24.3% | +5.8% | +17.2% | -12.5% | +8.0% | -9.0% | -8.6% | -16.5% | -3.3% | +38.4% | -3.9% | +4.8% | +4.7% | -7.8% | +6.3% | +4.0% | -8.8% | +8.9% | +3.0% |
| YoY Change | — | — | — | — | -17.9% | +17.1% | +0.7% | -21.4% | -25.0% | -32.8% | +2.2% | +7.5% | +34.8% | +46.0% | -2.8% | +7.5% | +6.7% | -7.0% | +9.8% | +6.4% |